本月全球药品研发进展取得成效的药物有46个,比上月增加了7个,除进入注册阶段的药品数量大幅增加外,进入注册前和Ⅲ期临床研究的药品数量均有所减少。进入注册阶段的有25个,比上月大幅增加了11个。其中10个为全球首次注册的新活性物质和新制剂,其余 There were 46 drugs that made progress in drug research and development globally this month, an increase of 7 last month. The number of drugs entering pre-registration and phase III clinical studies has dropped, with the exception of a substantial increase in the number of drugs entering the registration phase. There were 25 registrations, a substantial increase of 11 from the previous month. Among them, 10 were the first new active substances and new preparations registered in the world, and the rest